Episode Details
Back to Episodes
Artios Raises 115M for DDR Trials, Microclots Reveal Long COVID Clues, Genetic Key Alters Seasonal Mammal Behavior, Star Beyond Solar System Ejects CME, and more...
Published 4 months, 4 weeks ago
Description
(0:10): Artios Pharma Raises $115M to Boost DDR Cancer Pipeline with Promising New Trials
(2:15): Study Reveals Microclots and NETs as Key Biomarkers for Diagnosing Long COVID
(4:01): Breakthrough: Genetic Key to Seasonal Behavior in Mammals Unlocked by New Study
(5:47): First Ever Coronal Mass Ejection Detected from Star Beyond Solar System, Impacts Exoplanet Habitability
(7:32): BioRestorative's BRTX-100 Gains FDA Fast Track: Aims for Accelerated Phase 3 Trial for Back Pain Therapy
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: COINTURK FINANCE
(2:15): Study Reveals Microclots and NETs as Key Biomarkers for Diagnosing Long COVID
(4:01): Breakthrough: Genetic Key to Seasonal Behavior in Mammals Unlocked by New Study
(5:47): First Ever Coronal Mass Ejection Detected from Star Beyond Solar System, Impacts Exoplanet Habitability
(7:32): BioRestorative's BRTX-100 Gains FDA Fast Track: Aims for Accelerated Phase 3 Trial for Back Pain Therapy
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: COINTURK FINANCE